178 related articles for article (PubMed ID: 22774405)
1. Can we decrease the acute proctitis in prostate cancer patients using hyaluronic acid during radiation therapy: a prospective historically controlled clinical study.
Stefanelli A; Pascale G; Rainieri E; Ursino S; Colella M; Zini G; Berretta M; Fiorica F
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):639-45. PubMed ID: 22774405
[TBL] [Abstract][Full Text] [Related]
2. Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study.
Sanguineti G; Franzone P; Marcenaro M; Foppiano F; Vitale V
Strahlenther Onkol; 2003 Jul; 179(7):464-70. PubMed ID: 12835883
[TBL] [Abstract][Full Text] [Related]
3. A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer.
Hille A; Schmidberger H; Hermann RM; Christiansen H; Saile B; Pradier O; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1488-93. PubMed ID: 16137837
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients.
Khan AM; Birk JW; Anderson JC; Georgsson M; Park TL; Smith CJ; Comer GM
Am J Gastroenterol; 2000 Aug; 95(8):1961-6. PubMed ID: 10950043
[TBL] [Abstract][Full Text] [Related]
5. Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study.
Maggio A; Magli A; Rancati T; Fiorino C; Valvo F; Fellin G; Ricardi U; Munoz F; Cosentino D; Cazzaniga LF; Valdagni R; Vavassori V
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):518-24. PubMed ID: 24803033
[TBL] [Abstract][Full Text] [Related]
6. [Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy].
Freund U; Schölmerich J; Siems H; Kluge F; Schäfer HE; Wannenmacher M
Strahlenther Onkol; 1987 Oct; 163(10):678-80. PubMed ID: 3313776
[TBL] [Abstract][Full Text] [Related]
7. Can we decrease the acute proctitis in prostate cancer patients using hyaluronic acid during radiation therapy: a prospective historically controlled clinical study.
Cartei G
Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1279. PubMed ID: 23690202
[No Abstract] [Full Text] [Related]
8. Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot study.
Singh AK; Ménard C; Guion P; Simone NL; Smith S; Crouse NS; Godette DJ; Cooley-Zgela T; Sciuto LC; Coleman J; Pinto P; Albert PS; Camphausen K; Coleman CN
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1008-13. PubMed ID: 16730138
[TBL] [Abstract][Full Text] [Related]
9. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
Vordermark D; Guckenberger M; Baier K; Markert K
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
[No Abstract] [Full Text] [Related]
10. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
[TBL] [Abstract][Full Text] [Related]
11. Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer.
Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin J; Lizarde J; Macedo J; Ravera J; Tokita KM
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):824-30. PubMed ID: 20510195
[TBL] [Abstract][Full Text] [Related]
12. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis.
Hille A; Christiansen H; Pradier O; Hermann RM; Siekmeyer B; Weiss E; Hilgers R; Hess CF; Schmidberger H
Strahlenther Onkol; 2005 Sep; 181(9):606-14. PubMed ID: 16170489
[TBL] [Abstract][Full Text] [Related]
13. Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial.
Arcangeli S; Strigari L; Soete G; De Meerleer G; Gomellini S; Fonteyne V; Storme G; Arcangeli G
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):39-45. PubMed ID: 18538488
[TBL] [Abstract][Full Text] [Related]
14. A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis.
O'Brien PC; Franklin CI; Dear KB; Hamilton CC; Poulsen M; Joseph DJ; Spry N; Denham JW
Radiother Oncol; 1997 Nov; 45(2):117-23. PubMed ID: 9424000
[TBL] [Abstract][Full Text] [Related]
15. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
[TBL] [Abstract][Full Text] [Related]
16. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients.
Goldner G; Tomicek B; Becker G; Geinitz H; Wachter S; Zimmermann F; Wachter-Gerstner N; Reibenwein J; Glocker S; Bamberg M; Feldmann H; Pötzi R; Molls M; Pötter R
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):78-83. PubMed ID: 17189064
[TBL] [Abstract][Full Text] [Related]
17. Rectal bleeding after radiation therapy for prostate cancer: endoscopic evaluation.
Moore EM; Magrino TJ; Johnstone PA
Radiology; 2000 Oct; 217(1):215-8. PubMed ID: 11012447
[TBL] [Abstract][Full Text] [Related]
18. How Much Daily Image-guided Volumetric Modulated Arc Therapy Is Useful for Proctitis Prevention With Respect to Static Intensity Modulated Radiotherapy Supported by Topical Medications Among Localized Prostate Cancer Patients?
Ferini G; Tripoli A; Molino L; Cacciola A; Lillo S; Parisi S; Umina V; Illari SI; Marchese VA; Cravagno IR; Borzì GR; Valenti V
Anticancer Res; 2021 Apr; 41(4):2101-2110. PubMed ID: 33813420
[TBL] [Abstract][Full Text] [Related]
19. Hyperbaric oxygen therapy for radiation induced proctopathy in men treated for prostate cancer.
Dall'Era MA; Hampson NB; Hsi RA; Madsen B; Corman JM
J Urol; 2006 Jul; 176(1):87-90. PubMed ID: 16753375
[TBL] [Abstract][Full Text] [Related]
20. Effect of a prostaglandin--given rectally for prevention of radiation-induced acute proctitis--on late rectal toxicity. Results of a phase III randomized, placebo-controlled, double-blind study.
Kertesz T; Herrmann MK; Zapf A; Christiansen H; Hermann RM; Pradier O; Schmidberger H; Hess CF; Hille A
Strahlenther Onkol; 2009 Sep; 185(9):596-602. PubMed ID: 19756426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
